GGrantIndex
Sort

23,748 grants matching melanoma

Project 1: TLR4 as a Novel Target for Skin Cancer Prevention

$197,660
Georg T Wondrak · University Of Arizona · P01 · FY2023 · CA

A prognostic mRNA immune signature for resected stage II-III melanoma

$197,614
Yvonne Margaret Saenger · Columbia University Health Sciences · UH2 · FY2019 · CA

Investigating Helios as a regulator of natural killer cell effector maturation

$197,576
Barbara Lynne Kee · University Of Chicago · R21 · FY2023 · AI

Novel Nanostructures for Topical Photodynamic Therapy

$197,557
Lynntech, Inc. · R43 · FY2004 · CA

Rare Tumor Clinical Research Specialist

$197,518
Theodore Willis Laetsch · Children'S Hosp Of Philadelphia · R50 · FY2025 · CA

Novel Nanostructures for Topical Photodynamic Therapy

$197,499
Lynntech, Inc. · R43 · FY2003 · CA

Core 2: RXR Rexinoid Design and Synthesis

$197,418
Venkatram Reddy Atigadda · University Of Alabama At Birmingham · P01 · FY2019 · CA

Administrative Core

$197,388
Meenhard Herlyn · Wistar Institute · P50 · FY2022 · CA

Conditioning Patients to Increase DC-vaccine Potency

$197,379
Joseph Wayne Fay · Baylor Research Institute · P01 · FY2008 · CA

Targeted Advertising for Cancer Prevention

$197,315
Eleni Linos · University Of California, San Francisco · DP2 · FY2017 · CA

Clinically Annotated Human Melanoma for TMEN Research

$197,279
Keith T Flaherty · University Of Tx Md Anderson Can Ctr · U54 · FY2015 · CA

Sunlight and Melanomagenesis

$197,277
Paul D Chastain · Univ Of North Carolina Chapel Hill · R21 · FY2011 · ES

VPF/VEGF IN NORMAL AND NEOPLASTIC SKIN ANGIOGENESIS

$197,218
Massachusetts General Hospital · R01 · FY2002 · CA

ROLE OF THE TCL-5 GENE IN ACUTE T CELL LEUKEMIA AND MELANOMA

$197,196
Thomas Jefferson University · R01 · FY2002 · CA

ROLE OF THE TCL-5 GENE IN ACUTE T CELL LEUKEMIA AND MELANOMA

$197,196
Thomas Jefferson University · R01 · FY2001 · CA

Leveraging Health Systems to Increase Implementation of Evidence-based Surgical Cancer Care

$197,173
Kristy Kummerow Broman · University Of Alabama At Birmingham · K08 · FY2023 · CA

Leveraging Health Systems to Increase Implementation of Evidence-based Surgical Cancer Care

$197,173
Kristy Kummerow Broman · University Of Alabama At Birmingham · K08 · FY2024 · CA

Leveraging Health Systems to Increase Implementation of Evidence-based Surgical Cancer Care

$197,173
Kristy Kummerow Broman · University Of Alabama At Birmingham · K08 · FY2025 · CA

Admin Core

$197,147
Iman Osman · New York University School Of Medicine · P50 · FY2025 · CA

DENDRITIC CELL THERAPIES ELICIT EFFECTIVE ANTITUMOR RESPONSES

$197,104
University Of Pittsburgh At Pittsburgh · P01 · FY2000 · CA

CORE--IMMUNOLOGIC MONITORING AND DIAGNOSTIC LABORATORY

$197,104
University Of Pittsburgh At Pittsburgh · P01 · FY2000 · CA

Core D: Medicinal Chemistry Core

$197,103
Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA

Human Immunology Core

$197,102
Eline Tjetske Luning Prak · University Of Pennsylvania · P30 · FY2016 · CA

Suppressing Radiotherapy-Induced Metastasis in Aggressive Breast Cancers via 'On-Demand' siRNA Delivery from Responsive Polymer Nanoparticles

$197,067
Millicent O Sullivan · University Of Delaware · R21 · FY2019 · EB

Recruitment of melanoma-specific CD4+ T cells

$197,055
Matthew A Williams · University Of Utah · R21 · FY2016 · CA